PORIB aims to demonstrate the efficiency of a health intervention, relating its cost and the health outcomes or benefits it brings to patients, their caregivers and society, through:
PORIB aims to achieve the value-based pricing of the drug or medical device and its public financing, for inclusion in the pharmaceutical provision, therefore PORIB is focused on:
Health interventions must demonstrate to the Health Authorities their level of innovation, socioeconomic value, incremental clinical benefit, therapeutic usefulness, cost-effectiveness and budgetary impact. For this purpose, PORIB delivers:
Information on the safety and efficacy of a health intervention must be complemented with effectiveness-based data to demonstrate the benefits of that intervention in the “real-world” (RWE), in routine clinical practice. For this purpose, PORIB develops:
PORIB develops studies that review and synthesise the available clinical, economic, humanistic and social evidence on health interventions through:
In addition, PORIB collaborates with experts in the development of documents describing the results of a health research, a scientific evidence study or an economic evaluation, through:
The efficient management of resources allows improving the response of the Healthcare System to the needs and preferences of patients and their caregivers (“patient centricity”), offering sustainable services that allow the adaptation to a greater demand for care, with an improvement in the productivity of the healthcare professionals. PORIB is involved in the development of:
For improving access to any medicine or health intervention, it is necessary to know the perception and expectations of the different stakeholders: patients (including patient associations), health professionals, health administration, managers, health economists and politicians. For this purpose, PORIB carries out Advisory Boards, deliberative processes, or face-to-face and virtual meetings with the aim of:
Biostatistics provides the necessary knowledge and understanding of health outcomes to objectively communicate available information and achieve an efficient application of existing socioeconomic resources. In this area, PORIB performs:
PORIB delivers general and tailored training on concepts and methodology of Health Economics and Real-World Evidence (RWE)/Health Outcomes Research, through:
PORIB aims to achieve the value-based pricing of the drug or medical device and its public financing, for inclusion in the pharmaceutical provision, therefore PORIB is focused on:
Health interventions must demonstrate to the Health Authorities their level of innovation, socioeconomic value, incremental clinical benefit, therapeutic usefulness, cost-effectiveness and budgetary impact. For this purpose, PORIB delivers:
Information on the safety and efficacy of a health intervention must be complemented with effectiveness-based data to demonstrate the benefits of that intervention in the "real-world" (RWE), in routine clinical practice. For this purpose, PORIB develops:
PORIB develops studies that review and synthesise the available clinical, economic, humanistic and social evidence on health interventions through:
In addition, PORIB collaborates with experts in the development of documents describing the results of a health research, a scientific evidence study or an economic evaluation, through:
The efficient management of resources allows improving the response of the Healthcare System to the needs and preferences of patients and their caregivers ("patient centricity"), offering sustainable services that allow the adaptation to a greater demand for care, with an improvement in the productivity of the healthcare professionals. PORIB is involved in the development of:
For improving access to any medicine or health intervention, it is necessary to know the perception and expectations of the different stakeholders: patients (including patient associations), health professionals, health administration, managers, health economists and politicians. For this purpose, PORIB carries out Advisory Boards, deliberative processes, or face-to-face and virtual meetings with the aim of:
Biostatistics provides the necessary knowledge and understanding of health outcomes to objectively communicate available information and achieve an efficient application of existing socioeconomic resources. In this area, PORIB performs:
PORIB delivers general and tailored training on concepts and methodology of Health Economics and Real-World Evidence (RWE)/Health Outcomes Research, through: